Companies · Other Health Care
YANKTON · Other Health Care
Diligence memoA one-page analyst read on Lewis & Clark Specialty Properties Llc — recommendation, valuation, rhythm, risks.→Lewis & Clark Specialty Properties Llc looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Lewis & Clark Specialty Properties Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Lewis & Clark Specialty Properties Llc is one of 5377 Other Health Care companies tracked from YANKTON. By capital raised it ranks in the long tail (ahead of 29% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seed — a round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 29% of sector peers (real $). Modeled value above 38% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #147 of 351.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Chrysallis, Inc. | Pre-Seed | $1.7M | $30.8M | 3.33× |
| RefillDRS, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Ageology LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Great Lakes Healthcare Fund I, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| CreateHealth, Inc. | Pre-Seed | $1.0M | $30.8M | 3.33× |
| PHHC Investors II, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Eden Therapeutics Inc | Pre-Seed | $1.0M | $30.8M | 3.33× |
| LiveHealthier, Inc. | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Health News Inc | Pre-Seed | $1.0M | $30.8M | 3.33× |
| RxAlly, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Resuscitation International, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Integrated Medical Partners, LLC | Pre-Seed | $1.0M | $30.8M | 3.33× |
| Lewis & Clark Specialty Properties Llc this company | Pre-Seed | $807K | $12.1M | 1.31× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $279K | 2009-10-14 | $1.5M | $8.6M | 90% |
| Pre-Seed | $136K | 2009-12-31 | $756K | $4.2M | 90% |
| Pre-Seed | $392K | 2011-08-02 | $2.2M | $12.1M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| DANIEL JOHNSON | — | 4 other | 2009-10 |
| Daniel C. Johnson | — | 2 other | 2011-08 |
| Daniel J Saale | — | 2 other | 2009-12 |
| Allen Sossan | — | 1 other | 2009-10 |
| Catherine C. Wright | — | 1 other | 2011-08 |
| Catherine Wright | — | 1 other | 2009-12 |
| David Abbott | — | 1 other | 2009-10 |
| David J. Abbott | — | 1 other | 2011-08 |
| Don D. Swift | — | 1 other | 2011-08 |
| Don Swift | — | 1 other | 2009-10 |
| Douglas D. Neilson | — | 1 other | 2011-08 |
| Douglas Neilson | — | 1 other | 2009-10 |
| Joseph Boudreau | — | 1 other | 2009-10 |
| Joseph R. Boudreau | — | 1 other | 2011-08 |
| Kynan C. Trail | — | 1 other | 2011-08 |
| Kynan Trail | — | 1 other | 2009-10 |
| Lisa Miller | — | 1 other | 2009-10 |
| Paula Hicks | — | 1 other | 2009-10 |
| Scott Shindler | — | 1 other | 2009-10 |
| Thomas J. Posch | — | 1 other | 2011-08 |
| Scott L. Shindler | — | — | 2011-08 |
Lewis & Clark Specialty Properties Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Lewis & Clark Specialty Hospital Llc | Hospitals and Physicians | Pre-Seed | $1.1M | $14.1M | network20 shared operators · same stage |
| NuePath 2, LLC | Other Health Care | Pre-Seed | $300K | $470K | network1 shared operator · same sector · same stage |
| Peer Review Mediation & Arbitration Inc | Other Health Care | Pre-Seed | $803K | $13.7M | same sector · same stage |
| Pavilion Surgicenter, Llc | Other Health Care | Pre-Seed | $801K | $12.4M | same sector · same stage |
| M2Gen Holdings, L.P. | Other Health Care | Pre-Seed | $800K | $12.2M | same sector · same stage |
| SkyWriter MD, Inc. | Other Health Care | Pre-Seed | $800K | $13.9M | same sector · same stage |
| DataBiologics, Inc. | Other Health Care | Pre-Seed | $815K | $11.2M | same sector · same stage |
| Paraffin International, Inc. | Other Health Care | Pre-Seed | $820K | $9.9M | same sector · same stage |
See where Lewis & Clark Specialty Properties Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Lewis & Clark Specialty Properties Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.